Page last updated: 2024-08-23

buserelin and Pelvic Pain

buserelin has been researched along with Pelvic Pain in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kitawaki, J; Kusuki, I; Suganuma, I; Yamanaka, K1
Bier, UW; Bühler, K; Kato, K; Regidor, M; Regidor, PA; Schindler, AE1

Trials

1 trial(s) available for buserelin and Pelvic Pain

ArticleYear
Maintenance therapy with dienogest following gonadotropin-releasing hormone agonist treatment for endometriosis-associated pelvic pain.
    European journal of obstetrics, gynecology, and reproductive biology, 2011, Volume: 157, Issue:2

    Topics: Adult; Buserelin; Dose-Response Relationship, Drug; Drug Therapy, Combination; Endometriosis; Female; Gonadotropin-Releasing Hormone; Hormone Antagonists; Humans; Middle Aged; Nandrolone; Pelvic Pain; Prospective Studies; Time Factors; Treatment Outcome; Uterine Hemorrhage

2011

Other Studies

1 other study(ies) available for buserelin and Pelvic Pain

ArticleYear
Long-term follow-up on the treatment of endometriosis with the GnRH-agonist buserelinacetate. Long-term follow-up data (up to 98 months) of 42 patients with endometriosis who were treated with GnRH-agonist buserelinacetate (Suprecur), were evaluated in re
    European journal of obstetrics, gynecology, and reproductive biology, 1997, Volume: 73, Issue:2

    Topics: Adult; Buserelin; Endometriosis; Evaluation Studies as Topic; Female; Follow-Up Studies; Humans; Incidence; Infertility, Female; Pelvic Pain; Pregnancy; Pregnancy Outcome; Receptors, LHRH; Recurrence; Surveys and Questionnaires; Time Factors; Treatment Outcome

1997